ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0043

Non-invasive Tape Strip Gene Expression Profiling of Lesional Juvenile Dermatomyositis Skin Identifies Immunoregulatory Module That Associates with Skin, Muscle and Global Disease Activity

Jessica Turnier1, Celine Berthier2, Madison McClune2, Sarah Vandenbergen2, Johann Gudjonsson2, Alex Tsoi2 and J. Michelle Kahlenberg2, 1University of Michigan, Saline, MI, 2University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2022

Keywords: Bioinformatics, Biomarkers, dermatomyositis, Pediatric rheumatology, skin

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Skin inflammation in juvenile dermatomyositis (JDM) frequently persists even in the absence of active muscle disease. Tape stripping is a non-invasive skin sampling method that can be combined with transcriptome profiling to understand the connection of cutaneous signatures to disease activity. The objectives in this study were to 1) define gene expression signatures in lesional and non-lesional JDM skin recovered with tape stripping and 2) determine association of expression signatures with clinical disease activity.

Methods: We utilized tape stripping to collect lesional (L) and non-lesional (NL) skin in a JDM cohort (n=28 with ≥1 NL; n=18 with ≥1 paired L) and healthy controls (CTL; n=20, NL only). JDM patients met 2017 EULAR/ACR classification criteria and had standardized disease activity measures collected, including the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Manual Muscle Testing (MMT-8), and Physician’s Global Assessment of Disease Activity (PGA). mRNA was extracted from tape strips and RNA-seq libraries were generated and sequenced through the University of Michigan Advanced Genomics Core. Differentially expressed genes (DEGs; p-adjusted≤10%) between groups were identified using Limma-Voom. Literature-based pathway and network analyses were performed using Ingenuity Pathway Analysis (IPA) and Genomatix Pathway System (GePS). Weighted gene co-expression network analysis (WGCNA) was used to identify gene modules that were correlated with clinical measures. We also performed cell type enrichment analysis (xCell).

Results: JDM_L compared to CTL revealed 929 upregulated and 53 downregulated genes, with interferon signaling noted as the top upregulated pathway (p< 0.0001). Literature-based central nodes unique to JDM_L included ISG15, ICAM1 and CSF1, genes involved in interferon response, immune cell trafficking and macrophage regulation (Figure 1). JDM_NL demonstrated 4,138 upregulated and 329 downregulated genes compared to CTL, with regulated pathways predominantly involved in metabolism, angiogenesis and calcium signaling. JDM_L and JDM_NL relative to CTL displayed an overlap of 537 DEGs and highlighted common upregulation of the inflammasome pathway (p=0.0129), with increased CASP1, an activator of IL1B and IL18 (Figure 1). WGCNA of JDM_L identified 17 gene modules, with module 3 expression scores being positively associated with CDASI activity (r=0.78, p=0.002) and PGA (r=0.63, p=0.02) and negatively associated with MMT-8 (r=-0.66, p=0.014) (Figure 2). Module 3 was enriched for processes involving complement, innate immune system, apoptosis, T-cell and TNF receptors (Figure 3). Cell type enrichment analysis demonstrated enrichment for myeloid cell signatures, with M1 macrophage signatures in JDM_NL correlating with CDASI activity (r=0.6, p=0.0007), MMT-8 (r=-0.43, p=0.026) and PGA (r=0.39, p=0.042).

Conclusion: Tape stripping in JDM skin is feasible and able to identify gene expression changes associated with disease activity. Further analysis into association of modular expression signatures from tape stripping with disease activity and response to therapy has the potential to develop precision medicine approaches to JDM care.

Supporting image 1

Figure 1. Transcriptomic comparison of JDM_L and JDM_NL skin compared to CTL (q-value ≤ 10%) using DEGS to generate GePS networks. The pictures display the 100 best connected genes co-cited in PubMed abstracts in the same sentence linked to a function word (most relevant genes/interactions). Orange represents the genes that are upregulated and green represent the genes that are downregulated in JDM_NL and/or JDM_L compared to CTL.

Supporting image 2

Figure 2. Association of gene modules identified by WGCNA with JDM clinical features and disease activity measures. Heatmap displaying the correlation value of z-scores from the JDM_L WGCNA gene expression modules with clinical correlates. Each column represents a gene module, each row represents a different clinical correlate. Correlation coefficients are depicted using the color scale shown with red and green indicating positive and negative correlation respectively. Significant associations on the heatmap are depicted by an asterisk (p-value<0.05).

Supporting image 3

Figure 3. Dot plot representation of the top regulated GePS pathway-based networks (lower case) and pathway transduction networks (upper case) from JDM_L selected WGCNA modules (p<0.05). The dot size represents the number of genes regulated in each pathway compared to the total number of genes in the pathway (gene ratio). The dot color represents the -log(p-value).


Disclosures: J. Turnier, None; C. Berthier, None; M. McClune, None; S. Vandenbergen, None; J. Gudjonsson, None; A. Tsoi, None; J. Kahlenberg, AstraZeneca, Bristol-Myers Squibb(BMS), Eli Lilly, GlaxoSmithKlein(GSK), Janssen, Merck/MSD, Gilead.

To cite this abstract in AMA style:

Turnier J, Berthier C, McClune M, Vandenbergen S, Gudjonsson J, Tsoi A, Kahlenberg J. Non-invasive Tape Strip Gene Expression Profiling of Lesional Juvenile Dermatomyositis Skin Identifies Immunoregulatory Module That Associates with Skin, Muscle and Global Disease Activity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/non-invasive-tape-strip-gene-expression-profiling-of-lesional-juvenile-dermatomyositis-skin-identifies-immunoregulatory-module-that-associates-with-skin-muscle-and-global-disease-activity/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-invasive-tape-strip-gene-expression-profiling-of-lesional-juvenile-dermatomyositis-skin-identifies-immunoregulatory-module-that-associates-with-skin-muscle-and-global-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology